M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Amneal Pharmaceuticals, Inc. to acquire Saol Therapeutics' Baclofen Franchise
Announced Jan 5, 2022 · Closed Jan 5, 2022 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Amneal Pharmaceuticals, Inc. (AMRX)
- Target
- Saol Therapeutics' Baclofen Franchise
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jan 5, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Leerink Partners
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations